Andrew Orth

Insider Reports History

Entity
Individual
Location
2100 Wharton Street, Suite 701, Pittsburgh, PA
Signature
/s/ Andrew Orth
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Orth:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Krystal Biotech, Inc. Chief Commercial Officer Stock Option (Right to Buy) 37.5K $3.07M $81.91 Jun 9, 2023 Direct
Krystal Biotech, Inc. Chief Commercial Officer Performance Stock Units 10K $1.72M $171.66 Feb 28, 2023 Direct
Krystal Biotech, Inc. Chief Commercial Officer Common Stock 100 $13K $130.00 Jun 9, 2023 Direct

Insider Reports Filed by Andrew Orth

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KRYS Krystal Biotech, Inc. Jun 9, 2023 5 -$813K 4 Jun 9, 2023 Chief Commercial Officer
KRYS Krystal Biotech, Inc. Feb 28, 2023 2 $0 4 Feb 28, 2023 Chief Commercial Officer
KRYS Krystal Biotech, Inc. Feb 28, 2022 1 $0 4 Mar 1, 2022 Chief Commercial Officer
KRYS Krystal Biotech, Inc. May 31, 2021 1 $0 4 Jun 2, 2021 Chief Commercial Officer
KRYS Krystal Biotech, Inc. May 1, 2021 0 $0 3 May 11, 2021 Chief Commercial Officer